- Home
- FTFT vs IMRN Comparison
FTFT vs IMRN Comparison
Compare FTFT & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- IMRN
- Stock Information
- Founded
- FTFT N/A
- IMRN 1994
- Country
- FTFT United States
- IMRN Australia
- Employees
- FTFT N/A
- IMRN N/A
- Industry
- FTFT Business Services
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- IMRN Health Care
- Exchange
- FTFT Nasdaq
- IMRN Nasdaq
- Market Cap
- FTFT 11.0M
- IMRN 9.2M
- IPO Year
- FTFT N/A
- IMRN N/A
- Fundamental
- Price
- FTFT $1.89
- IMRN $1.81
- Analyst Decision
- FTFT
- IMRN Strong Buy
- Analyst Count
- FTFT 0
- IMRN 1
- Target Price
- FTFT N/A
- IMRN $5.00
- AVG Volume (30 Days)
- FTFT 155.3K
- IMRN 82.1K
- Earning Date
- FTFT 08-26-2025
- IMRN 09-08-2025
- Dividend Yield
- FTFT N/A
- IMRN N/A
- EPS Growth
- FTFT N/A
- IMRN N/A
- EPS
- FTFT N/A
- IMRN N/A
- Revenue
- FTFT $2,031,913.00
- IMRN $4,048,286.00
- Revenue This Year
- FTFT N/A
- IMRN N/A
- Revenue Next Year
- FTFT N/A
- IMRN N/A
- P/E Ratio
- FTFT N/A
- IMRN N/A
- Revenue Growth
- FTFT N/A
- IMRN 82.90
- 52 Week Low
- FTFT $1.01
- IMRN $1.50
- 52 Week High
- FTFT $5.70
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- FTFT 46.86
- IMRN 58.51
- Support Level
- FTFT $1.52
- IMRN $1.62
- Resistance Level
- FTFT $1.96
- IMRN $1.84
- Average True Range (ATR)
- FTFT 0.24
- IMRN 0.09
- MACD
- FTFT -0.08
- IMRN 0.02
- Stochastic Oscillator
- FTFT 40.66
- IMRN 89.55
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.